Statistics
Publications
7
Citations
159
H-Index
7
Active since
2015
Affiliations
Lingyi Shi is an author at Wenzhou Medical University specializing in pharmacology, apoptosis, and cancer cell signaling.
Publications per year
2015–2024
7
7
Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
Lingyi Shi, Hailun Zheng, Wanle Hu et al. · OncoTargets and Therapy · 2017 · 40 citations · Full text
Medicine, Oncology, Pharmacology +15
Anti-Lung Cancer Activity of the Curcumin Analog JZ534 In Vitro
Jianzhang Wu, Zhijian Cai, Xiaoyan Wei et al. · BioMed Research International · 2015 · 21 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 7